CMV Clinical Trials in Guangzhou, Guangdong
3 recruitingGuangzhou, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Takeda80 enrolled53 locationsNCT05319353
Recruiting
Phase 3
A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections
Cytomegalovirus (CMV)
Takeda20 enrolled12 locationsNCT06439342
Recruiting
Prospective Cohort Study of Complications and Outcomes in Cirrhosis
Decompensated CirrhosisCMV ReactivationOvert Hepatic Encephalopathy
Nanfang Hospital, Southern Medical University660 enrolled1 locationNCT06374511